Clinical Trials

The health care industry energetically strives to improve remedies to existing diseases and to develop countermeasures to new health risks.

At the same time, there has been an increasing shift towards livestyle drugs and enhanced or functional food and beverage products, attracting new market participants from related industries.

And while ever tightening regulatory approval requirements necessitate stringent clinical testing, both before and after market introduction of new products, Japanese companies are increasingly shifting their clinical trials overseas.

As leaders in clinical trial insurance, HDI-Gerling is committed to offer some of the most comprehensive and competitive coverage available.

To respond the specific needs of local pharmaceutical and medical equipment manufacturers, HDI-Gerling has developed its unique Clinical Trial Insurance for the Japanese market, i.e. the "No Fault Compensation Insurance for Clinical Trials and/or Human Volunteers Studies".

However, as Clinical Trials may differ, e.g. in terms of geographical spread or regulatory requirements, HDI-Gerling offers a broad variety of tailor-made products, i.e.

• Single trial or multi-centre policies
• Japanese policies and both coordinated or integrated International Clinical Trial Programs
• Non-fault Compensation and/or Legal Liability cover
• Japanese or English policy form

Our products are supported by dedicated, highly professional, technical experts with specialist underwriting and claims knowledge including the requirements of local legislation and Ethics Committees around the world.

Contact information

If you want to know more about the HDI-Gerling Clinical Trial Insurance or if you require a quotation for a specific trial, please contact us at

E-Mail: chiken@hdi-gerling.jp